Refinement of response assessment in neuro-oncology (RANO) using non-enhancing lesion type and contrast enhancement evolution pattern in IDH wild-type glioblastomas.

BMC Cancer · 2021 · PMC8170938 · PMID 34074252

Europe PMC DOI

hedged sentence

0.1960

closest p · 3.9× alpha

0.1960

boldest claim

The sentences

did not reach statistical significanceP = .196not close (p > 0.1)

However, this difference did not reach statistical significance (HR = 1.37, P = .196) (Supplementary Fig. 1 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.